van Beusechem, V.W., van den Doel, P.B., Grill, J., Pinedo, H.M., and Gerritsen, W.R. (2002). Conditionally replicative adenovirus expressing p53 exhibits enhanced oncolytic potency. Cancer Res. (52, 6165-6171.
van Houdt, I.S., Sluijter, B.J.R., Moesbergen, L.M., Vos, W.M., de Gruijl, T.D., Molenkamp,
B. G., van den Eertwegh, A.J.M., Hooijberg, E., van Leeuwen, P.A.M., Meijer,
C. J.L.M., and Oudejans, J.J. (2008). Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression. Int. J. Cancer 123, 609-615.
van Pesch, V., Lanaya, H., Renauld, J.-C., and Michiels, T. (2004). Characterization of the murine alpha interferon gene family. J. Virol. 78, 8219-8228. van Rikxoort, M., Michaelis, M., Wolschek, M., Muster, T., Egorov, A., Seipelt, J., Doerr, H.W., and Cinatl, J., Jr. (2012). Oncolytic effects of a novel Influenza A virus expressing interleukin-15 from the NS reading frame. PLoS ONE 7, e36506.
Vandepol, S.B., Lefrancois, L., and Holland, J.J. (1986a). Seąuences of the major antibody binding epitopes of the Indiana serotype of vesicular stomatitis virus. Virology 148, 312-325.
Vandepol, S.B., Lefranęois, L., and Holland, J.J. (1986b). Sequences of the major antibody binding epitopes of the Indiana serotype of Vesicular Stimatitis Virus. Virol. J. 148, 312-325.
Vanderplasschen, A., Mathew, E., Hollinshead, M., Sim, R.B., and Smith, G.L. (1998). Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. Proceedings of the National Academy of Sciences 95, 7544-7549.
Veerapong, J., Bickenbach, K.A., Shao, M.Y., Smith, K.D., Posner, M.C., Roizman, B., and Weichselbaum, R.R. (2007). Systemie delivery of yl34.5-deleted Herpes Simplex Virus-1 selectively targets and treats distant human xenograft tumors that express high MEK activity. Cancer Res. 67, 8301-8306.
Venkatesha, R T, Thangam, E.B., Zaidi, A.K., and Ali, H. (2005). Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and P13 kinase. Mol. Immunol. 42, 581-587.